drogy-info.cz

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is set to evolve into the European Union Drugs Agency (EUDA) on July 2, 2024. This transformation will enhance the agency's capacity to address the complexities of drug-related issues in Europe. The EUDA will serve as a vital resource for policymakers, researchers, and the public, providing independent, scientifically validated knowledge on drug usage, drug markets, and associated health responses across the EU member states.

The agency focuses on various key areas including cannabis policy, drug-related deaths, treatment demands, and emerging synthetic drugs. It also employs a collaborative approach, working alongside the 27 EU member states and beyond, to monitor trends and develop effective prevention strategies. Furthermore, the EUDA will provide access to data catalogues, statistical bulletins, and best practice toolkits aimed at enhancing public health responses to drug problems. With its comprehensive resources, the EUDA is committed to fostering a safer, healthier Europe through informed drug policies and practices.